Available online the Abstracts for Rottapharm Biotech’s poster and oral presentations at the ACR/ARHP Annual Meeting, San Francisco, November 6-12, 2015

Available online the Abstracts for Rottapharm Biotech’s poster and oral presentations at the ACR/ARHP Annual Meeting, San Francisco, November 6-12, 2015

Read our Abstracts about CRB0017, a novel anti-ADAMTS5 monoclonal antibody (mAb) intended for therapeutic use as a potential disease-modifying osteoarthritis drug (DMOAD). The Abstracts were assigned an oral and a poster presentation, respectively, and are available online at the following addresses: